1662 related articles for article (PubMed ID: 16380497)
1. Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy.
Susztak K; Raff AC; Schiffer M; Böttinger EP
Diabetes; 2006 Jan; 55(1):225-33. PubMed ID: 16380497
[TBL] [Abstract][Full Text] [Related]
2. Impact of high glucose and transforming growth factor-β on bioenergetic profiles in podocytes.
Stieger N; Worthmann K; Teng B; Engeli S; Das AM; Haller H; Schiffer M
Metabolism; 2012 Aug; 61(8):1073-86. PubMed ID: 22365040
[TBL] [Abstract][Full Text] [Related]
3. Antioxidants ameliorate the expression of vascular endothelial growth factor mediated by protein kinase C in diabetic podocytes.
Lee EY; Chung CH; Kim JH; Joung HJ; Hong SY
Nephrol Dial Transplant; 2006 Jun; 21(6):1496-503. PubMed ID: 16484238
[TBL] [Abstract][Full Text] [Related]
4. Schisandra chinensis fruit extract attenuates albuminuria and protects podocyte integrity in a mouse model of streptozotocin-induced diabetic nephropathy.
Zhang M; Liu M; Xiong M; Gong J; Tan X
J Ethnopharmacol; 2012 May; 141(1):111-8. PubMed ID: 22353431
[TBL] [Abstract][Full Text] [Related]
5. Spironolactone inhibits hyperglycemia-induced podocyte injury by attenuating ROS production.
Toyonaga J; Tsuruya K; Ikeda H; Noguchi H; Yotsueda H; Fujisaki K; Hirakawa M; Taniguchi M; Masutani K; Iida M
Nephrol Dial Transplant; 2011 Aug; 26(8):2475-84. PubMed ID: 21220752
[TBL] [Abstract][Full Text] [Related]
6. Podocyte hypertrophy in diabetic nephropathy.
Kim NH
Nephrology (Carlton); 2005 Oct; 10 Suppl():S14-6. PubMed ID: 16174280
[TBL] [Abstract][Full Text] [Related]
7. Gemigliptin improves renal function and attenuates podocyte injury in mice with diabetic nephropathy.
Jung E; Kim J; Ho Kim S; Kim S; Cho MH
Eur J Pharmacol; 2015 Aug; 761():116-24. PubMed ID: 25977232
[TBL] [Abstract][Full Text] [Related]
8. Redistribution of connexin43 expression in glomerular podocytes predicts poor renal prognosis in patients with type 2 diabetes and overt nephropathy.
Sawai K; Mukoyama M; Mori K; Yokoi H; Koshikawa M; Yoshioka T; Takeda R; Sugawara A; Kuwahara T; Saleem MA; Ogawa O; Nakao K
Nephrol Dial Transplant; 2006 Sep; 21(9):2472-7. PubMed ID: 16820374
[TBL] [Abstract][Full Text] [Related]
9. Altered gene expression related to glomerulogenesis and podocyte structure in early diabetic nephropathy of db/db mice and its restoration by pioglitazone.
Makino H; Miyamoto Y; Sawai K; Mori K; Mukoyama M; Nakao K; Yoshimasa Y; Suga S
Diabetes; 2006 Oct; 55(10):2747-56. PubMed ID: 17003339
[TBL] [Abstract][Full Text] [Related]
10. Renal podocyte apoptosis in Zucker diabetic fatty rats: involvement of methylglyoxal-induced oxidative DNA damage.
Kim J; Sohn E; Kim CS; Kim JS
J Comp Pathol; 2011 Jan; 144(1):41-7. PubMed ID: 20541219
[TBL] [Abstract][Full Text] [Related]
11. Mechanical stretch and prostaglandin E2 modulate critical signaling pathways in mouse podocytes.
Faour WH; Thibodeau JF; Kennedy CR
Cell Signal; 2010 Aug; 22(8):1222-30. PubMed ID: 20362052
[TBL] [Abstract][Full Text] [Related]
12. Activated protein C protects against diabetic nephropathy by inhibiting endothelial and podocyte apoptosis.
Isermann B; Vinnikov IA; Madhusudhan T; Herzog S; Kashif M; Blautzik J; Corat MA; Zeier M; Blessing E; Oh J; Gerlitz B; Berg DT; Grinnell BW; Chavakis T; Esmon CT; Weiler H; Bierhaus A; Nawroth PP
Nat Med; 2007 Nov; 13(11):1349-58. PubMed ID: 17982464
[TBL] [Abstract][Full Text] [Related]
13. Podocyte-specific Nox4 deletion affords renoprotection in a mouse model of diabetic nephropathy.
Jha JC; Thallas-Bonke V; Banal C; Gray SP; Chow BS; Ramm G; Quaggin SE; Cooper ME; Schmidt HH; Jandeleit-Dahm KA
Diabetologia; 2016 Feb; 59(2):379-89. PubMed ID: 26508318
[TBL] [Abstract][Full Text] [Related]
14. BMP7 is a podocyte survival factor and rescues podocytes from diabetic injury.
Mitu GM; Wang S; Hirschberg R
Am J Physiol Renal Physiol; 2007 Nov; 293(5):F1641-8. PubMed ID: 17804487
[TBL] [Abstract][Full Text] [Related]
15. mTORC2 Signaling Regulates Nox4-Induced Podocyte Depletion in Diabetes.
Eid S; Boutary S; Braych K; Sabra R; Massaad C; Hamdy A; Rashid A; Moodad S; Block K; Gorin Y; Abboud HE; Eid AA
Antioxid Redox Signal; 2016 Nov; 25(13):703-719. PubMed ID: 27393154
[TBL] [Abstract][Full Text] [Related]
16. Poly(ADP-ribose) polymerase inhibitors ameliorate nephropathy of type 2 diabetic Leprdb/db mice.
Szabó C; Biser A; Benko R; Böttinger E; Suszták K
Diabetes; 2006 Nov; 55(11):3004-12. PubMed ID: 17065336
[TBL] [Abstract][Full Text] [Related]
17. Attenuation of interstitial fibrosis and tubular apoptosis in db/db transgenic mice overexpressing catalase in renal proximal tubular cells.
Brezniceanu ML; Liu F; Wei CC; Chénier I; Godin N; Zhang SL; Filep JG; Ingelfinger JR; Chan JS
Diabetes; 2008 Feb; 57(2):451-9. PubMed ID: 17977949
[TBL] [Abstract][Full Text] [Related]
18. Olmesartan Prevents Microalbuminuria in db/db Diabetic Mice Through Inhibition of Angiotensin II/p38/SIRT1-Induced Podocyte Apoptosis.
Gu J; Yang M; Qi N; Mei S; Chen J; Song S; Jing Y; Chen M; He L; Sun L; Hu H; Li L; Wüthrich RP; Wu M; Mei C
Kidney Blood Press Res; 2016; 41(6):848-864. PubMed ID: 27871084
[TBL] [Abstract][Full Text] [Related]
19. Alterations of the podocyte proteome in response to high glucose concentrations.
Schordan S; Schordan E; Endlich N; Lindenmeyer MT; Meyer-Schwesinger C; Meyer TN; Giebel J; Cohen CD; Endlich K; Maurer MH
Proteomics; 2009 Oct; 9(19):4519-28. PubMed ID: 19688724
[TBL] [Abstract][Full Text] [Related]
20. The podocyte and diabetes mellitus: is the podocyte the key to the origins of diabetic nephropathy?
Reddy GR; Kotlyarevska K; Ransom RF; Menon RK
Curr Opin Nephrol Hypertens; 2008 Jan; 17(1):32-6. PubMed ID: 18090667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
